Immunoliposome co-delivery of bufalin and anti-CD40 antibody adjuvant induces synergetic therapeutic efficacy against melanoma
Ying Li,1,* Jiani Yuan,1,* Qian Yang,1 Wei Cao,1 Xuanxuan Zhou,1 Yanhua Xie,1 Honghai Tu,2 Ya Zhang,1 Siwang Wang1 1Department of Natural Medicine and Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, People’s Republic of China; 2Instit...
Main Authors: | Li Y, Yuan J, Yang Q, Cao W, Zhou X, Xie Y, Tu H, Zhang Y, Wang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/immunoliposome-co-delivery-of-bufalin-and-anti-cd40-antibody-adjuvant--peer-reviewed-article-IJN |
Similar Items
-
Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma
by: Hei Y, et al.
Published: (2020-03-01) -
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
by: Saeed M, et al.
Published: (2016-03-01) -
Immunoliposomes in haematology
by: Gray, Atherton
Published: (1992) -
Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes
by: Huiqin Zhuo, et al.
Published: (2018-03-01) -
Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy
by: Gils Jose, et al.
Published: (2020-10-01)